Postoperative rehabilition after reverse shoulder arthroplasty withelectric muscle stimulation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00030880

Enrollment

Registered

2023-07-04

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICD-10-GM: Z96.60 – Presence of shoulder prosthesis

Interventions

Group 1: Standardized rehabilitation programm of the periscapular muscules for 6 weeks with additional muscle stimulation using a shoulder pacemaker Group 2: Standardized rehabilitation programm of th

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient specific inclusion criteria: 1. Patient of legal age (m/f/d) and capable of consent with a 2. Primary osteoarthritis with rotator cuff lesion or 3. Massive rotator cuff lesion or 4. Cuff tear arthropathy, that was 5. treated by a reverse shoulder arthroplasty. Case specific inclusion criteria: 1. Treatment of the given pathologies of the shoulder with a uncemented reverse shoulder arthroplasty using 2. The same uncemented short stem (Aequalis Ascend Flex, Stryker). 3. Start of intervention between 12 to 24 months after the surgery.

Exclusion criteria

Exclusion criteria: 1. Unable to contact for recruitment due to missing/outdated contact information/data 2. Cases with a acute fracture, avascular necrosis or revision cases 3. Prior surgery on the affected shoulder or 4. Postoperative complications (periprosthetic fracture, loosening, infection etc.) with or without a revision of the case 5. Contraindications to a therapy using electric stimulation around the shoulder 6. Secondary illnesses, that affect the connective tissue (e.g. Marfan syndrome, Ehlers-Danlos syndrome, scleroderma) 7. Secondary illnesses, that affect the nervous system (e.g. parkinsons disease, multiple sclerosis, peripheral neuropathy) 8. Secondary illnesses, that affect the muscle tissue (e.g. Mitochondrial myopathies, muscular dystrophies, myotonic syndromes) 9. Secondary rheumatic diseases.

Design outcomes

Primary

Measure	Time frame
Contant Shoulder Score	—

Secondary

Measure	Time frame
Range of Motion, Subjective Shoulder Value	—

Countries

Germany

Contacts

Public ContactPatric Raiss

OCM Klinik

patric.raiss@ocm-muenchen.de+49 89 2060820

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026